Compare RPC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPC | IRMD |
|---|---|---|
| Founded | 1992 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.2M | 1.1B |
| IPO Year | 2021 | 2014 |
| Metric | RPC | IRMD |
|---|---|---|
| Price | $8.06 | $81.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $11.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 514.9K | 78.8K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.96% | 0.95% |
| EPS Growth | 6.25 | ★ 16.67 |
| EPS | 0.14 | ★ 0.86 |
| Revenue | ★ $297,346,000.00 | $83,814,000.00 |
| Revenue This Year | $16.82 | $12.38 |
| Revenue Next Year | $15.80 | $11.31 |
| P/E Ratio | ★ $58.00 | $97.16 |
| Revenue Growth | 0.30 | ★ 14.43 |
| 52 Week Low | $6.79 | $67.84 |
| 52 Week High | $9.51 | $107.90 |
| Indicator | RPC | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.92 | 28.37 |
| Support Level | $7.34 | $76.95 |
| Resistance Level | $8.02 | $88.93 |
| Average True Range (ATR) | 0.28 | 2.13 |
| MACD | -0.09 | -0.24 |
| Stochastic Oscillator | 3.54 | 5.03 |
Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.